Legal Representation
Attorney
Ralph G. Fischer
USPTO Deadlines
Next Deadline
1973 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-24)
Due Date
December 24, 2030
Grace Period Ends
June 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 24, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 24, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 22, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 22, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 2, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 13, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 11, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 11, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 10, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 25, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 25, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 25, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 23, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 7, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 7, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 7, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 6, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 11, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicines for human medical purposes in the nature of pharmaceutical preparations for the use in the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicines for veterinary purposes for treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceuticals and natural remedies, namely, natural remedy preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicines for the treatment of Alzheimer's disease; Medicines for the treatment of neurodegenerative diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical purposes; Injectable pharmaceuticals for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Medicinal preparations and substances for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Agents against Parkinson's disease, namely, pharmaceutical agents for the treatment of Parkinson's disease; Pharmaceutical medicines in the nature of pharmaceutical preparations for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical products for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical preparations for human use for the treatment of neurodegenerative diseases, Alzheimer's disease, cardiovascular and cerebrovascular diseases, central nervous system, Parkinson's disease; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of cerebral disease; Pharmaceutical preparations for the treatment of central nervous system diseases
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research, clinical research and medical research in the field of pharmaceuticals; Medical research laboratory services; Conducting technical tests on pharmaceuticals; Conducting analysis of human serum for medical research; Conducting analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research relating to pharmaceuticals; Research and development in the field of pharmacy and biotechnology; Clinical research in the field of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Quality testing for pharmaceutical products; Scientific research in the field of pharmacy; Scientific research and development
Class 044
Medication counseling; Providing information to patients in the field of administering medications; Providing medical information relating to pharmaceutical products; Providing information relating to the treatment of degenerative diseases; Providing information relating to medical services; Medical advisory services relating to degenerative diseases; Medical consultancy and medical information services relating to pharmaceutical products; Medical consultancy and medical information services relating to pharmaceutical products provided via the Internet; Medical consultancy and medical information services relating to medical products; Medical consultancy services relating to medicines; Medical services; Medical services for the treatment of Alzheimer's disease; Pharmaceutical compounding services; Preparation and administration of medicines being medical services
Classification
International Classes
005
042
044